FORWARD FEATURES CALENDAR

Deals

Drugs 2

Water Street Invests in pharmaceutical services company

Water Street Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, has invested in CCBR-SYNARC.   Comprised of two businesses that specialise in outsourced clinical services, CCBR-SYNARC expands Water Street’s global presence in the pharmaceutical services sector. It also marks the healthcare firm’s first investment from its

Rockpool completes investment in Chicago Rib Shack

Rockpool Investments, the private equity investment firm headed by Nicola Horlick, has completed a first close of a planned GBP1.675m investment in Chicago Rib Shack, the fast casual dining restaurant founded and operated by Christian Arden.   The EIS-qualifying investment, which was taken up by members of the Rockpool Network

RJD achieves fourth exit from its second fund with the GBP50m sale of Ipes

RJD Partners has exchanged contracts to realise its investment in Ipes, one of Europe’s leading providers of fund administration and outsourcing services, in a buyout backed by Silverfleet Capital. The transaction values Ipes at GBP50m, giving a return to RJD of 3x its original investment. Final completion is subject to

Segulah IV sells Medstop to Oriola-KD

Segulah IV has entered into an agreement to sell 100 per cent of the shares in Medstop Group to Oriola-KD.   The transaction, which is subject to the approvals of the Swedish Competition Authority (Konkurrensverket) and the Swedish Medical Products Agency (Läkemedelsverket), values the company to SEK1,460m including an estimate

Maven acquires Fundamental Tracker Investment Management

Maven Capital Partners, a private equity and alternative asset manager, has completed the acquisition of Fundamental Tracker Investment Management (FTIM) from City of London Group.   The primary business of FTIM is The Munro UK Dividend Fund, a passive tracker OEIC which will be rebranded under the Maven name in

GenSight Biologics raises EUR32m in a Series A financing for ophthalmic gene therapy

GenSight Biologics, a biopharmaceutical company focused on the development of ophthalmic therapeutics using gene therapy, has closed a EUR32m Series A financing.   The financing was co-led by Novartis Venture Fund, Abingworth, Versant Ventures and Index Ventures.   GenSight will use the funds to develop a gene replacement therapy for

Plane taking off

Arlington Capital Partners teams with management to acquire MB Aerospace

Private equity firm Arlington Capital Partners has acquired MB Aerospace in partnership with the company’s management team.   Headquartered in Motherwell, UK, MB Aerospace is a provider of highly engineered components for the commercial and military aero-engine and industrial gas turbine markets.   MB Aerospace manufactures complex rings, casings and

North Castle Partners invests in Ignite USA

North Castle Partners and its co-investors have completed an investment of growth capital in Ignite USA, a developer and marketer of reusable, environmentally friendly thermal mugs and hydration bottles.   North Castle is a private equity firm focused on investments in consumer-driven companies that promote healthy, active and sustainable living. 

Events

12 November, 2026 – 5:00 pm

Directory Listings